Bausch & Lomb Incorporated

This study tests a new eye drop called BL1107 against a standard treatment (timolol) in 252 adults with glaucoma or high eye pressure. The goal is to see if BL1107 is safe and improves vision better than the current option. Participants will use the drops for about a month and ha…

This study was designed to check the long-term safety of a new eye drop combination for people with dry eye disease. It planned to follow participants for 12 months to see if any side effects occurred. However, the trial was withdrawn before any volunteers were enrolled.

This early-stage study tests a new eye drop called BL1332 in 24 healthy adults aged 18 to 50. The goal is to see if the drops are safe and tolerable, and to find the highest dose that can be given without causing serious side effects. This research is a first step toward possibly…

This study tests a new type of lens (enVista Beyond) placed in the eye during cataract surgery. The goal is to see if it helps people see clearly at far, middle, and near distances without needing glasses. About 304 adults with cataracts are taking part to check the lens's safety…

This study tests a new excimer laser used in LASIK eye surgery to correct farsightedness (hyperopia), with or without astigmatism. About 140 adults aged 22 and older will have the procedure and be followed for 12 months. The goal is to see if the laser safely improves vision with…